55154-5095 : Propafenone Hydrochloride 150 mg Oral Tablet


NDC55154-5095
Labeler: Cardinal Health
Product Type: Human Prescription Drug
Drug Name:  Propafenone Hydrochloride
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA075998
Rev. Date: 


Appearance:


Markings: MP;511
Shapes:  Round
Colors:  White
Size (mm): 9
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

MP 511: (53489-551) Propafenone Hydrochloride 150 mg Oral Tablet by Cardinal Health
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 55154-5095-0: 10 BLISTER PACK IN 1 BAG (55154‑5095‑0) > 1 TABLET, FILM COATED IN 1 BLISTER PACK

Active Ingredients:

  • Propafenone Hydrochloride

Dosage Strength:

  • 150 mg

Inactive Ingredients:

  • Carnauba Wax
  • Hypromelloses
  • Magnesium Stearate
  • Polydextrose
  • Polyethylene Glycols
  • Polysorbate 80
  • Povidone
  • Starch, Corn
  • Propylene Glycol
  • Sodium Starch Glycolate Type a Potato
  • Titanium Dioxide
  • Triacetin

Pharmaceutical Classes:

  • Antiarrhythmic [EPC]

Related Products:

Based on records with the same trade name.
  • 0378-1258 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-1259 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0378-1261 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.
  • 0591-2285 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-2286 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-2287 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0603-5448 Propafenone Hydrochloride 150 mg Oral Tablet by Qualitest Pharmaceuticals
  • 0603-5449 Propafenone Hydrochloride 225 mg Oral Tablet by Qualitest Pharmaceuticals
  • 0603-5450 Propafenone Hydrochloride 300 mg Oral Tablet by Qualitest Pharmaceuticals
  • 0615-7574 Propafenone Hydrochloride 150 mg Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 16714-825 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Northstar Rx LLC
  • 16714-826 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Northstar Rx LLC
  • 16714-827 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Northstar Rx LLC
  • 42291-545 Propafenone Hydrochloride 225 mg Oral Capsule, Extended Release by Avkare, Inc.
  • 42291-546 Propafenone Hydrochloride 325 mg Oral Capsule, Extended Release by Avkare, Inc.
  • 42291-547 Propafenone Hydrochloride 425 mg Oral Capsule, Extended Release by Avkare, Inc.
  • 49884-099 Propafenone Hydrochloride 225 mg 12 Hr Extended Release Capsule by Par Pharmaceutical, Inc.
  • 49884-113 Propafenone Hydrochloride 225 1/1 Oral Capsule, Extended Release by Par Pharmaceutical, Inc.
  • 49884-210 Propafenone Hydrochloride 325 mg 12 Hr Extended Release Capsule by Par Pharmaceutical, Inc.
  • 49884-211 Propafenone Hydrochloride 425 mg 12 Hr Extended Release Capsule by Par Pharmaceutical, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55154-5095 QR Code

< Prev: 55154-5094Next: 55154-5096 >

Related Discussions:

Propafenone HCl
## Has anyone else experienced a trembling/vibrating/buzzing sensation after taking this drug? If so, did you ever find ... 1 reply
Propafenone+V5124
Different code than previous rx...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA